Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 16, 1999 - Issue 2
Submit an article Journal homepage
57
Views
42
CrossRef citations to date
0
Altmetric
Research Article

LIPOSOMAL DAUNORUBICIN (DAUNOXOME) IN CHILDREN WITH RECURRENT OR PROGRESSIVE BRAIN TUMORS

R. J. J. Lippens Centre for Pediatric Oncology South East Netherlands, Nijmegen, The Netherlands
Pages 131-139 | Published online: 09 Jul 2009

References

  • Levin VA. A pharmacologic basis for brain tumor chemotherapy. Semin Oncol. 1975;2:57–61.
  • Mooney C, Thomas DGT, Souhami RL. Adriamycin in the treatment of relapsed primary malignant brain tumors. Eur J Cancer Clin Oncol. 1983;19:1037–1038.
  • Benjamin RS, Weernik PH, Bachur NR. Adriamycin chemotherapy: efficacy, safetyand pharmacologic basis of an intermittent, single high-dose schedule. Cancer. 1974;33:19–27.
  • Bigotte L, Olson Y. Cytofluoresce localization of adriamycin in the nervous system, III: distribution in the brain of normal adult mice after intraventricular and arachnoidal injection. Acta Neuropathol (Berl). 1982;58:193–202.
  • Niewelt EA, Pagel M, Barrett P, Glassberg M, Frenkel EP. Pharmacology and toxicity of intracarotid adriamycin administration following osmotic blood-brain barrier modification. Cancer Res. 1981;41: 4466–4470.
  • Todorov DK, Ninjo SS, Zeller WJ. Antiproliferadve activity of liposomal epirubicin on experimental human glioma in vitro and in vivo after intratum oral/interstitial application. J Cancer Res Clin Oncol. 1995;121:164–168.
  • Gill PS, Espina BM, Muggia F, et al. Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. J Clin Oncol. 1995;13:996–1003.
  • Gennuso R, Spiegelman MK, Chinot M, et al. Effect of blood-brain barrier and blood-tumor barrier modification on central nervous system liposomal uptake. Cancer Invest. 1993;11:118–128.
  • Gabizon AA. Selective tumor localization and improved therapeutic index of anthracyclines encap-sulated in long-circulating liposomes. Cancer Res. 1992;52:891–896.
  • Siegal T, Horowitz A, Gabizon A. Doxorubicin encapsulated in spherically stabilized liposomes for the treatment of a brain tumor model: biodistribution and therapeutic efficacy. JNeurosurg. 1995;83:1029–1037.
  • Van tongelen K, coordinator editor. A Practical Guide to EORTC Studies. Brussels: EORTC; 1994.
  • Sobotka-Plojhar MA. Anthracycline Cardiotoxi city in Children: An Echocardiographic Study. Amsterdam, The Netherlands: VU University Press; 1991:20. Thesis.
  • Pound P, Bonoron-Adele AS, Gouverneur G, Tariosse L, Besse g RobertJ. Development of the model of rat isolated perfused heart for the evaluation of anthracycline cardio toxicity and its circumvention. Br J Pharmacol. 1996;117:1593–1599.
  • Janknegt R. Liposomal formulations of cytotoxic drugs. Support Care Cancer. 1996;4:298–304.
  • Forssen EA, Coulter DM, Proffitt RT. Selective in vivo localization of daunomycin small unilamellar vesicles in solid tumors. Cancer Res. 1992;52:3255–3261.
  • Forssen EA, Male-Brune R, Adler-Moore JP, Lee MJ, Schmidt PG, Keasieva TB, Shimizu S, Tromberg BJ. Fluorescence imaging studies for the disposition of daunorubicin liposomes (DaunoXome) within tumor tissue. Cancer Res. 1996;56:2066–2075.
  • Forssen EA, Ross IR: DaunoXome treatment of solid tumours: pre clinical and clinical investigation. Liposome Res. 1994;4:481–512.
  • Vestar IC: DaunoXome (Liposomal Daunorubicin). Physician's brochure for named patient use in Europe for Kaposi's sarcoma. San Dimas, CA; 1993.
  • Rosa P, Clem enti F. Liposomes containing doxorubicin: an example of drug targetting. In: Antoline R, ed. Transport in Biomembranes: Model Systems and Reconstruction. New York: Raven; 1982:243.
  • Tokes ZA, StPeteri AK, Todd JA. Availability of liposome content to the nervous system: liposomes and the blood-brain barrier. Brain Res. 1980;188:282–286.
  • Guaglianone P, Chan K, DelaFlor-Weiss E, et al. Phase I and pharmacologic study of liposomal daunorubicin (DaunoXome). Invest New Drugs. 1994;12:103–110.
  • Gabizon AA. Liposomal anthracyclines. Hem atol Oncol Clin North Am. 1994;8;431–450.
  • Bayley CC, chairman. UKCCSG/SIOP P.N.E.T. Study III (UKCCSG 9102). Leicester, UK; 1992.
  • Pendergrass TW, Milstein JM, Geyer JR, et al. Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy. J Clin Oncol. 1987;5:1221–1231.
  • Göbel U, Calaminus G, Teske C, et al. BEP/VIP bei Kinder und Jugendlichen mit malignen nicht-testi-kuldren Keimzelltumoren. Klin Padiat. 1993;205:231.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.